MaxCyte, Rivian Automotive And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session.

• Cambium Networks Corporation CMBM shares dipped 27.8% to $5.72 in pre-market trading after the company reported preliminary revenue for the third quarter. Cambium Networks said it sees revenues of $40 million to $45 million, versus prior forecast of $62 million to $70 million. The company also suspended its guidance for the full year 2023.
• MaxCyte, Inc. MXCT shares tumbled 21.4% to $2.57 in pre-market trading. MaxCyte said it sees third-quarter total revenue of $7.8 to 8.0 million, representing a decrease of 25% -27% versus the year-ago quarter. The company now expects total revenue of approximately $34 million to $36 million for the year.
• Accolade Inc ACCD shares declined 9.2% to $8.85 in pre-market trading after the company reported second-quarter results. Accolade said it sees FY24 revenue of $410 million to $414 million.
• Rivian Automotive, Inc. RIVN shares fell 8.7% to $21.63 in pre-market trading after announcing a debt offering. Alongside this, the company also provided a preliminary print of its third-quarter revenue, which fell in line with expectations.
• Resources Connection, Inc. RGP shares fell 8.5% to $13.25 in pre-market after the company reported first-quarter financial results.
• Nanobiotix S.A. NBTX shares declined 8% to $8.23 in pre-market trading. Nanobiotix announced presentation of the final efficacy analysis from Phase 1 cohort expansion evaluating NBTXR3 in locally advanced head and neck cancer showing median progression-free survival of 16.9 months and median overall survival of 23.1 months.
• Lithium Americas (Argentina) Corp LAAC shares fell 5% to $5.71 in pre-market trading.
• The Clorox Company CLX shares fell 4.6% to $125.76 in pre-market trading after the company reported preliminary first-quarter financial results.

Now Read This: Investor Fear Eases Amid Pullback In Treasury Yields

Don’t forget to check out our premarket coverage here